These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7887428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.
    Sherratt TG, Vulliamy T, Dubowitz V, Sewry CA, Strong PN.
    Am J Hum Genet; 1993 Nov; 53(5):1007-15. PubMed ID: 8213828
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.
    Nguyen TM, Morris GE.
    Am J Hum Genet; 1993 Jun; 52(6):1057-66. PubMed ID: 7684887
    [Abstract] [Full Text] [Related]

  • 6. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
    Winnard AV, Klein CJ, Coovert DD, Prior T, Papp A, Snyder P, Bulman DE, Ray PN, McAndrew P, King W.
    Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
    [Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies against the muscle-specific N-terminus of dystrophin: characterization of dystrophin in a muscular dystrophy patient with a frameshift deletion of exons 3-7.
    Le TT, Nguyen TM, Love DR, Helliwell TR, Davies KE, Morris GE.
    Am J Hum Genet; 1993 Jul; 53(1):131-9. PubMed ID: 8317478
    [Abstract] [Full Text] [Related]

  • 8. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers.
    Klein CJ, Coovert DD, Bulman DE, Ray PN, Mendell JR, Burghes AH.
    Am J Hum Genet; 1992 May; 50(5):950-9. PubMed ID: 1570844
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA, Saito T, Duddy W, Takeda S, Yokota T.
    Methods Mol Biol; 2018 May; 1828():141-150. PubMed ID: 30171539
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy.
    Schatzberg SJ, Anderson LV, Wilton SD, Kornegay JN, Mann CJ, Solomon GG, Sharp NJ.
    Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116
    [Abstract] [Full Text] [Related]

  • 14. Dystrophin expression in Duchenne patients with "in-frame" gene deletions.
    Nicholson LV, Bushby KM, Johnson MA, Gardner-Medwin D, Ginjaar IB.
    Neuropediatrics; 1993 Apr; 24(2):93-7. PubMed ID: 8327067
    [Abstract] [Full Text] [Related]

  • 15. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K, Beggs AH, Honda H, Ito S, Ishiura S, Tsukahara T, Ishiguro T, Eguchi C, Orimo S, Arikawa E.
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro.
    Ehrenpreis J, Hillers M, Junkes B, Pfordt M, Schwinger E, Vosberg HP.
    Genomics; 1991 Jul; 10(3):551-7. PubMed ID: 1889805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.